LivaNova PLC

NASDAQ: LIVN
$51.70
+$1.65 (+3.3%)
Closing Price on November 21, 2024

LIVN Stock Chart and Intraday Price

LIVN Stock Data

Asset Type Stock
Exchange NASDAQ
Currency USD
Country USA
Sector LIFE SCIENCES
Industry ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Address 20 EASTBOURNE TERRACE, LONDON, GB
Fiscal Year End December
Latest Quarter 12/31/2023
Market Cap 2,975.82M USD
Shares Outstanding 53,871,000
LivaNova PLC is a London-based global medical device company focused on developing innovative therapeutic solutions. Its product lineup spans across three main segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The company offers a range of products, including oxygenators, heart-lung machines, and devices for treating depression and epilepsy through vagus nerve stimulation. LivaNova is dedicated to improving patient outcomes in critical areas such as heart surgery and neurological conditions, serving healthcare professionals and institutions worldwide.

LIVN Articles

Monday's top analyst upgrades and downgrades included Altria, Archer Daniels Midland, Baidu, Beyond Meat, Bunge, General Electric, Hecla Mining, Kraft Heinz, Lowe’s Companies, Mosaic, Philip Morris...
Thursday's top analyst upgrades and downgrades included Carvana, FedEx, First Solar, Generac, Nike, PagSeguro Digital, Palantir Technologies, Redfin, Regions Financial, Starbucks, Target and Workday.